Analysis

Merck & Company, Inc. (MRK) Stock Analysis

Merck & Company, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to MRK.

websiteMRK/analysis/MRK

Merck & Company, Inc.

Merck & Company, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to MRK.

Stock profile

Ticker

MRK

Asset type

Stock

Market cap

$281.24B

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

USD

Ticker listings

Merck & Company, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • MRK primary listing
  • 6MK
  • MRKD
  • MRCK34
  • 1MRKX
  • A0YD8Q
  • MRKCL
  • MRK.USD

Latest Merck & Company, Inc. news

Merck and Mae Partner to Expand Doula Workforce and Address Maternal Health Disparities in High-Risk U.S. Markets

NEW YORK, June 23, 2026--Merck, through the company’s Merck for Mothers initiative, and Mae are collaborating on a multi-state effort to expand and sustain the community-based d...

Merck’s Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLAS-UC Induction-only Study in Patients With Moderately to ...

Merck’s Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLAS-UC Induction-only Study in Patients With Moderately to Severely Active

Study Reveals Dog Owners and Veterinarians See Challenges in Treating Allergic Skin Disease, Highlighting a Need for a Targeted Rapid Ons...

RAHWAY, N.J., June 17, 2026--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MR...

FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG® (belzutifan...

FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG® (belzutifan), for Adjuvant

Merck Animal Health to Acquire TARGAN

Merck Animal Health to Acquire

Research sections

Valuation

Review valuation context for Merck & Company, Inc..

Future growth

Review future growth context for Merck & Company, Inc..

Past performance

Review past performance context for Merck & Company, Inc..

Financial health

Review financial health context for Merck & Company, Inc..

Dividend

Review dividend context for Merck & Company, Inc..

Management

Review management context for Merck & Company, Inc..

Ownership

Review ownership context for Merck & Company, Inc..

Other information

Review other information context for Merck & Company, Inc..

Community

Review community context for Merck & Company, Inc..